primary neurons that will form, Xenopus homologs of the proneural genes appear to promote primary neurogenesis. At least three neural bHLH transcription factors, called XASH-3, X-NGNR-1, and NeuroD, have been identified that are expressed early on in the neural plate of Xenopus embryos. Two of these, X-NGNR-1 and NeuroD, are expressed in all three domains where primary neurons form, and when ectopically expressed, they promote the formation of ectopic neurons, even outside the neural plate Ma et al., 1996) . In contrast, XASH-3 shows a much more restricted expression pattern and ability to evoke neurogenesis upon ectopic expression (Zimmerman et al., 1993; Ferreiro et al., 1994; Turner and Weintraub, 1994; Chitnis and Kinter, 1996) . Recent experiments have indicated that X-NGNR-1 activates NeuroD in a unidirectional cascade. The ability of X-NGNR-1 to promote ectopic neurogenesis is repressed by lateral inhibition, and thus X-NGNR-1 behaves analogously to the proneural genes of Drosophila .
In this paper, we identify the Xenopus C2HC-type zinc finger protein X-MyT1 as a novel component of the neurogenic cascade in Xenopus. X-MyT1 is a sequencespecific DNA-binding protein that has originally been cloned from a human brain cDNA library on the basis of its ability to bind to cis-regulatory elements of the glia-specific myelin proteolipid protein (PLP) gene (Kim and Hudson, 1992) . Here, we show that X-MyT1 is expressed in the prospective primary neurons prior to N-tubulin, but shortly after X-NGNR-1. We provide evidence that X-MyT1 expression is being promoted by to lateral inhibition. These data suggest that X-MyT1 interacts with components of a cascade of bHLH prohighly conserved multigene family of proteins (data not teins to confer insensitivity to lateral inhibition, thereby shown). Proteins encoded by the corresponding Xenopromoting commitment to a neuronal fate.
pus and rat cDNAs are essentially identical in their structural organization when compared to each other or to the truncated MyT1 protein that was predicted from the Results partial human MyT1 cDNA ( Figure 1A ). For X-MyT1, this structural organization includes an approximately 40 X-MyT1-Type Proteins Have Been Highly Conserved in the Evolution of kDa amino-terminal domain that contains a prominent acidic cluster (26 acidic amino acids in 28) between Vertebrates and Invertebrates RT-PCR was used to isolate cDNA fragments encoding amino acid positions 245 and 272. This acidic aminoterminal domain is followed by a pair of C2HC-type zinc MyT1-type proteins from various vertebrate and invertebrate species, making use of degenerate oligonucleofingers that are separated by a Ser/Thr-rich spacer element from another group of four C2HC-type zinc fingers tide primers corresponding to common sequence elements of all six zinc finger modules in human MyT1 (Kim (Figure 1B) . We have also isolated a MyT1-type zinc finger protein encoding cDNA from C. elegans that conand Hudson, 1992) . Sequence analysis of these PCR products indicated that, with the exception of yeast, all tains only two C2HC-type zinc finger modules, corresponding to the amino-terminal cluster of the vertebrate eukaryotes tested encode C2HC-type zinc finger proteins and that such proteins were represented in some MyT1 proteins discussed. The vertebrate and nematode sequences, however, share little structural homology species by several distinct isolates, indicating that the MyT1-type zinc finger unit defines an evolutionarily outside of this zinc finger domain.
not evenly distributed throughout the neural plate, but fall into a pattern that is reminiscent of the neuronspecific N-tubulin gene, whose expression marks the formation of the primary neurons (Oschwald et al., 1991; Chitnis et al., 1995) (Figure 2A ). This correlation is even more evident by the completion of gastrulation (stage 12.5), when X-MyT1 expression is clearly restricted to three groups of cells arranged in a radially symmetrical pattern on either side of the dorsal midline of the posterior neural plate, where the ventral, intermediate, and dorsal groups of cells will differentiate into motor neurons, interneurons, and sensory neurons, respectively. Expression of X-MyT1 also appeared to correspond to sites of neurogenesis in the anterior neural plate, including expression by a lateral group of cells associated with the trigeminal placodes, by an extreme anterior group of cells associated with the olfactory placode, and by a central stripe of cells that corresponds to sites in the ventral midbrain and forebrain where neurons first form in the brain. The same pattern of expression is maintained in later-stage neurula embryos, as the lateral stripes of X-MyT1-expressing cells extend along and converge toward the dorsal midline. Thus, this analysis indicated that the expression of X-MyT1 appears to be restricted to the developing nervous system and early on, correlates extremely well with sites of primary neurogenesis. Expression of X-MyT1 significantly precedes the expression of N-tubulin during the earliest phases of neurogenesis. In the medial group of primary neurons in the posterior neural plate, for instance, N-tubulin expression is not detectable until advanced gastrula (stage 12.5), while X-MyT1 is already detected in the corresponding regions by early gastrulation (stage 11.5). A similar sequential expression of X-MyT1 and N-tubulin is seen in the anterior portion of the neural plate and in the trigemi- , expression of X-NGNR-1 precedes ing to primary neurons. This temporal order of expression correlates with a gradual sharpening of expression boundaries.
that of X-Delta-1 and can be detected in early gastrulae side of the embryo, revealing a pattern that clearly cor-X-Delta-1 is also strongly expressed in an area adjacent to the relates with the expression pattern of X-MyT1 and blastopore.
X-Delta-1. At neither of these early stages is expression of X-NeuroD detected (data not shown). Thus, these X-MyT1 Is an Early Marker observations show a clear, temporal order of appearof Primary Neurogenesis ance, with X-NGNR-1 being the first, X-MyT1 and To examine the role of X-MyT1 in Xenopus embryos, X-Delta-1 the second, and N-tubulin the third gene to we analyzed the early embryonic expression of X-MyT1 be activated in cells corresponding to primary neurons. using wholemount in situ hybridization (Figure 2A) . By This comparison also revealed an important spatial this analysis, X-MyT1 transcripts are first expressed at order to these genes. Each domain of cells expressing mid-late gastrulation (stage 11.5) within the dorsal ecto-X-NGNR-1 appears to be wider than that of X-MyT1 (and derm which, at this stage, is just beginning to form the that of X-Delta-1), which in turn is wider than those expressing N-tubulin. These spatial correlations were neural plate. The cells expressing X-MyT1, however, are further confirmed by double-labeling in situ hybridization ( Figure 2B ). X-MyT1 and X-Delta-1 were found to share identical domains of expression. In contrast, in embryos double-labeled with probes for X-MyT1 and N-tubulin, all cells within one stripe that express N-tubulin also express X-MyT1, whereas some cells located more laterally in respect to the dorsal midline stain with the X-MyT1 probe but are negative for N-tubulin. Thus, as a second characteristic difference, expression patterns generated by these genes are defined by a sharpening of expression boundaries, correlating with the temporal order of transcriptional activation described above. X-NGNR-1 stripes are broad, X-MyT1 stripes are more narrow, and N-tubulin defines a thin and precise line of cells.
To determine whether a similar relationship between X-MyT1, X-NGNR-1, X-Delta-1, and N-tubulin also holds true during secondary neurogenesis, we examined the expression of these genes in the developing nervous system of tailbud embryos. X-MyT1 transcripts are detectable in cranial ganglia, eye, olfactory placodes, pineal gland, and throughout the central nervous system; at tadpole stage, X-MyT1 expression decreases in the spinal cord but persists in the brain and sensory organs pression characteristics of the genes discussed above appear to reflect the progress of neuronal differentiation.
In summary, the expression of X-MyT1 is very similar expressed in a pattern similar to that of X-Delta-1, we to that of X-Delta-1, and both follow the expression of asked if X-MyT1 might also be activated by the ectopic X-NGNR-1, while all three anticipate, both spatially and expression of X-NGNR-1. Embryos were injected at the temporally, the formation of primary neurons as marked two-cell stage with X-NGNR-1 transcripts, along with by expression of N-tubulin. Like X-Delta-1 and X-NGNR-1, LacZ RNA as a tracer, and analyzed at the neural plate expression of X-MyT1 is transient and does not appear stage by wholemount staining for X-MyT1 expression, to occur once neurons terminally differentiate, sugas well as with X-gal staining to reveal the distribution gesting that X-MyT1 plays a role in early steps of neuof the injected RNA. The results show that ectopic ronal specification. Finally, there is a sharpening of X-NGNR-1 strongly activates the ectopic expression of expression boundaries during neurogenesis that corre-X-MyT1 (Figure 4 ). Based on these results and on the lates with the temporal order of expression, where temporal correlation of X-NGNR-1 and X-MyT1 expres-X-NGNR-1 stripes are broad, X-MyT1 stripes are more sion described above, we conclude that X-MyT1 is likely narrow, and N-tubulin defines a thin and precise line of to be transcriptionally activated, perhaps directly, by cells.
X-NGNR-1. Expression of X-MyT1, like that of X-Delta-1, occurs in scattered, isolated cells and anticipates the scattered X-MyT1 Expression Is Positively Regulated by X-NGNR-1 and Negatively Regulated pattern of primary neurons that forms as marked by N-tubulin expression. Previous studies indicated that by Lateral Inhibition Previously, we have shown that ectopic expression of the scattered pattern of neuronal differentiation is generated by lateral inhibition, an inhibitory cell-cell interac-X-NGNR-1 leads to ectopic expression of X-Delta-1 in early Xenopus embryos . Because the tion mediated by the receptor X-Notch-1 and its putative ligand X-Delta-1 . For instance, even comparison described above indicated that X-MyT1 is activate ectopic X-MyT1 expression is inhibited by activated Notch. As shown in Figure 4 , embryos injected with both Notch ICD and X-NGNR-1 RNA show no X-MyT1 expression. Thus, taken together, these results indicate that expression of X-MyT1, like that of the early neuronal-differentiation markers, is negatively regulated, perhaps directly, by the process of lateral inhibition. In addition, the tight correlation between the effects of lateral inhibition on N-tubulin, X-NGNR-1, and X-MyT1 expression provides further evidence that X-MyT1 is involved in neuronal specification.
X-MyT1 Promotes Neuronal Differentiation and Cooperates with bHLH Factors to Confer Insensitivity to Lateral Inhibition
The expression patterns of X-MyT1 in normal embryos, as well as in embryos with altered X-Notch-1 or X-NGNR-1 activities, suggest that X-MyT1 plays a role during neuronal specification. To determine if X-MyT1 is sufficient to induce ectopic neuronal differentiation, form, suggesting that X-MyT1 requires cofactors to promote ectopic formation of N-tubulin-expressing cells in fewer N-tubulin-expressing cells form when Notch sigother regions of the neural plate. Since the activity of the naling is increased, and more N-tubulin-expressing cells neural bHLH transcription factors is likely to be higher in form within each stripe when lateral inhibition is blocked.
the domains of the neural plate where neurons formed, Moreover, previous studies indicate that the expression one possibility is that X-MyT1 cooperates with these of X-NGNR-1 is regulated by lateral inhibition: its expresfactors to drive neuronal differentiation. sion is repressed by activated X-Notch-1 and is inTo test this idea, we first asked if X-MyT1 and XASH-3 creased when lateral inhibition is blocked. Because might cooperate to induce N-tubulin expression. Previ-X-NGNR-1 appears to regulate X-MyT1 expression, we ous studies have shown that XASH-3 can induce therefore asked if X-MyT1 expression is also regulated N-tubulin gene expression in noggin-treated animal by lateral inhibition. To test this, we examined X-MyT1 caps but not in naive ectoderm (Ferreiro et al., 1994) , expression in embryos in which Notch signaling is insuggesting that N-tubulin gene activation requires faccreased, either by expressing an activated form of tors in addition to XASH-3 that are activated during X-Notch-1, called Notch ICD, or by ectopically expressprimary neurogenesis. Moreover, ectopic expression of ing X-Delta-1 . In both cases, increas-XASH-3 did not induce X-MyT1 expression as was seen ing Notch signaling inhibited the expression of X-MyT1, in similar experiments with X-NGNR-1 (Figure 4 ; data not as predicted (Figure 4 ; data not shown). Conversely, shown). Therefore, embryos were injected with either embryos injected with an antimorphic form of X-Delta-1, XASH-3 or X-MyT1 RNA alone, or with a combination called X-Delta-1 Stu , which blocks lateral inhibition, exof both RNAs. Only the combination of both proteins hibit an increased density of N-tubulin-and X-NGNRresulted in strong ectopic expression of N-tubulin (Fig-1-expressing cells Ma et al., 1996) . ure 5A). The combination of XASH-3 and X-MyT1 also As predicted, the density of X-MyT1-expressing cells accelerated the onset of N-tubulin expression in emalso increases in embryos when lateral inhibition is bryos, inducing it as early as stage 11.5. To test whether blocked using X-Delta-1 Stu ( Figure 4 ). this combination is also effective in naive ectoderm, Because X-NGNR-1 appears to activate X-MyT1 exwe performed similar experiments using the animal cap pression and X-NGNR-1 expression is regulated by latexplant assay. Animal caps from embryos injected into eral inhibition , we cannot determine both blastomeres at the two-cell stage were dissected, from these results whether lateral inhibition directly regallowed to develop to the equivalent of tailbud stages, ulates X-MyT1 expression, or whether it acts indirectly and analyzed for N-tubulin expression by wholemount by regulating X-NGNR-1 expression. To examine this in situ hybridization. Strong N-tubulin induction was indeed observed in animal caps that had received both further, we asked whether the ability of X-NGNR-1 to XASH-3 and X-MyT1, but not with either one of the two alone ( Figure 5A ). Taken together, these results indicate that X-MyT1 can cooperate with XASH-3 to induce N-tubulin expression, even in the absence of neural induction.
In contrast to XASH-3, ectopic expression of a different bHLH protein, X-NGNR-1, can induce widespread N-tubulin expression in an unrestricted way . However, the ability of X-NGNR-1 alone to induce widespread N-tubulin expression may reflect the fact that it also activates the expression of X-MyT1 ( Figure  4) . Moreover, the ability of X-NGNR-1 to induce N-tubulin as well as the expression of X-MyT1 can be blocked by activated X-Notch-1 (Figure 4) . Thus, we asked if coinjection of X-MyT1 could overcome the inhibitory effects of activated X-Notch-1 on the proneural activity of X-NGNR-1. The experiment illustrated in Figure 5B reveals that embryos injected with Notch ICD, either in the presence or absence of X-NGNR-1, show reduced levels of N-tubulin expression. In contrast, embryos expressing X-MyT1, Notch ICD, and X-NGNR-1 express just as much N-tubulin as those expressing X-NGNR-1 alone. Similarly, embryos expressing Notch ICD, X-MyT1, and XASH-3 also reveal strong ectopic N-tubulin expression ( Figure 5B ). These observations appear to have two major implications. First, the fact that X-MyT1 can restore N-tubulin expression in embryos injected with both Notch ICD and X-NGNR-1 suggests that Notch ICD blocks the proneural activity of X-NGNR-1 by blocking its ability to activate X-MyT1 expression. Second, the fact that combining X-MyT1 with either XASH-3 or X-NGNR-1 produces N-tubulinexpressing cells even in the presence of Notch ICD suggests that X-MyT1 allows cells to escape lateral inhibition.
The results with X-MyT1 described above might be explained by a model in which X-MyT1 interfered with lateral inhibition, for instance by affecting the activity of X-Delta-1 or other components of the Notch signaling pathway. However, if this were the case, then X-MyT1 expression should also alter the expression of other genes that appear to be regulated during primary neurogenesis by lateral inhibition. To examine this possibility, we first asked whether X-MyT1 altered the normal expression pattern of X-Delta-1 or X-NGNR-1. If X-MyT1 inhibited the lateral inhibitory machinery, we would predict that the expression of both genes should increase since they are both normally inhibited by lateral inhibition. However, neither the expression of X-Delta-1 nor that of X-NGNR-1 was noticeably affected in embryos injected with X-MyT1 or with a combination of X-MyT1 and XASH-3 (data not shown). 6A). The latter bipartite consensus is a repetition of a perfect palindromic sequence, and it matches with the Taken together, these observations suggest that X-MyT1 interacts synergistically with X-NGNR-1 (or consensus sequences selected by the first two zinc fingers. The PLP promoter element that was used in the XASH-3) to activate N-tubulin expression. This interaction appears to be insensitive to inhibition by Notch original identification of a human MyT1 fragment contains only one copy of the core consensus, i.e., AAGTT signaling. Furthermore, X-MyT1 does not appear to promote the proneural activity of X-NGNR-1 or XASH-3 by (Kim and Hudson, 1992) . In a second approach, the DNA-binding specificity of an X-MyT1 protein fragment directly interfering with the lateral inhibitory machinery.
containing both finger domains was analyzed using a similar selection/amplification strategy, but starting with X-MyT1 Acts as a Transcriptional Activator; Decreasing Its Activity Affects the Pattern Hae III-digested total Xenopus laevis genomic DNA. All DNA fragments selected at high stringency were found of Neuronal Differentiation The results described so far indicate that X-MyT1 acts to contain multiple copies of the AAAGTTT core-consensus recognition sequence ( Figure 6A ). However, a comin concert with bHLH transcription factors to drive neuronal differentiation and that the activity of these bHLH parative data bank sequence analysis reveals that these genomic fragments are not likely to represent biologiproteins is X-MyT1-dependent. A more direct test of this idea is to decrease the activity of X-MyT1 in embryos cally relevant target sites for X-MyT1, since they correspond to spacer elements in the highly repetitive, ooand determine what effect this has on the formation of primary neurons. In order to carry out this test, we aimed cyte-specific, 5S ribosomal RNA-encoding transcription units (Fedoroff and Brown, 1977) . Binding of the different at designing X-MyT1 variants that would be capable of counteracting the activity of the endogenous protein in X-MyT1 variants to the selected DNA fragments was confirmed by DNaseI footprinting ( Figure 6B ). As exXenopus embryos. For this purpose, we defined the DNA-binding specificity of X-MyT1 and analyzed the pected, the X-MyT1 zinc finger clusters protect regions containing the (AAAGTTT)n motifs. Interestingly, all properties of X-MyT1 in terms of its activities in transcriptional regulation.
three X-MyT1 protein variants employed, containing either the first or the second group of C2HC fingers or both In a first approach, the DNA-binding specificity of each of the two X-MyT1 zinc finger clusters was anaof these together, produce virtually identical patterns of protection. lyzed separately by multiple rounds of selection/amplification from a pool of randomized oligonucleotides with Because zinc finger proteins that bind specific DNA sequences can function as transcription activators or as repressors, we tested X-MyT1 for such activities in transient transfection assays, using a reporter-gene construct that contains a MyT1 binding site in the form of two copies of the core-consensus sequence. The results show that in Hela cells, which do not contain detectable amounts of human MyT1 mRNA, expression of X-MyT1 stimulates transcription from this reporter construct in a dose-dependent manner ( Figure 7A ). Analysis of a systematic set of deletion mutants reveals that the central domain, which separates the two zinc finger clusters from each other, is required for this activity ( Figure 7B ). The same set of X-MyT1 deletion mutants was also tested for their ability to induce ectopic N-tubulin expression when overexpressed together with XASH-3 or with X-NGNR-1 in Notch ICD-injected embryos. All X-MyT1 deletion mutants active in the transfection assays were found to also be active in embryos, either in combination with XASH-3 or with X-NGNR-1/ Notch ICD ( Figure 7B ). Thus, fragments of X-MyT1 sufficient for transcriptional activation in transient transfections are also sufficient for a synergistic interaction with the bHLH transcription factors. Interestingly, and important for the design of the interfering X-MyT1 variant, only one of the two zinc finger clusters appears to be required for transactivation. Furthermore, a fusion protein containing the first X-MyT1 zinc finger cluster connected to the E1a activation domain is unable to cooperate with bHLH factors to induce N-tubulin expression (data not shown), providing support for the idea that the central domain might function via specific protein-protein interactions.
To determine whether X-MyTI is indeed required for neuronal differentiation, we tested two variants of X-MyT1 that we predicted would interfere with the ability of X-MyT1 to act as a transcriptional activator. In the first case, embryos were injected with RNA encoding just the central domain of X-MyT1 (X-MyT1-CD), with the idea that overexpressing this region would block specific protein-protein interactions required for X-MyT1 function as a transcriptional activator. Indeed, embryos expressing X-MyT1-CD do exhibit a significant reduction in the number of N-tubulin-expressing cells at neurula stages ( Figure 7C ; Table 1 ). Following an idea that has been successfully applied to the analysis of Embryos were injected into one cell at the two-cell stage with the RNAs as indicated. At the neural plate stage, embryos were scored for a decrease or an increase of N-tubulin expression as judged by the number of N-tubulin-positive cells and the intensity of the N-tubulin staining in the lateral stripes of the injected side. The number of embryos scored for each phenotype is expressed as a fraction of the total embryos examined.
both dominant-negative forms of X-MyT1 did not appear neuronal specification occurs. Temporally, X-MyT1 is to have a detectable effect on the expression of endogeexpressed after X-NGNR-1, but before N-tubulin and nous X-NGNR-1 (data not shown). The effects of both NeuroD. Spatially, X-MyT1 transcripts are detected in X-MyT1-CD and X-MyT1-ZF-engR on N-tubulin expresscattered cells within the primary areas of neuronal sion could be reversed by coinjecting an excess of specification and, importantly, the width of each of these wild-type X-MyT1, in accordance with the idea that both domains expressing X-MyT1 is narrower than that seen act as dominant-negative mutants (Table 1) . Finally, with X-NGNR-1, but broader than that seen with N-tubuwhen X-MyT1-ZF-engR is coexpressed with X-NGNR-1, lin. In both respects, this pattern of X-MyT1 expression the strong ectopic N-tubulin expression induced by is extremely similar to that of X-Delta-1 (Chitnis et al, X-NGNR-1 alone is significantly reduced ( Figure 7C ). In-1995) . Indeed, the same factors that control X-Delta-1 terestingly, in such embryos coinjected with X-NGNR-1 expression also appear to regulate X-MyT1 expression; and X-MyT1-ZF-engR , N-tubulin-expressing cells form both genes appear to be activated by X-NGNR-1, and in a more scattered pattern than that observed with both appear to be negatively regulated by the lateral X-NGNR-1 alone. Thus, these results suggest that inhibition process. Thus, we would like to suggest that X-MyT1 functions as a positive regulator of neuronal X-MyT1 can be placed in a position similar to that of differentiation, as assessed by N-tubulin gene transcrip-X-Delta-1 in the sequence of events that occur during tion. Decreasing X-MyT1 activity blocks neuronal differprimary neurogenesis, both in terms of its expression entiation, indicating that X-MyT1 is essential to neuronal pattern and how this pattern emerges through interacspecification.
tions between the proneural and neurogenic genes. Although they have similar expression patterns, Discussion X-MyT1 and X-Delta-1 appear to have opposing effects on neuronal differentiation. By activating the Notch sigIn this paper, we examine the role of X-MyT1 in the naling pathway, X-Delta-1 acts as an inhibitor of neuspecification of primary neurons in Xenopus embryos. ronal differentiation. In contrast, several of the findings We show that the expression of X-MyT1 is initiated durreported here suggest strongly that X-MyT1 promotes ing primary neurogenesis around the same time as the differentiation of neuronal cells. First, dominant-neg-X-Delta-1, perhaps by the direct action of X-NGNR-1.
ative forms of X-MyT1 inhibit both normal neurogenesis We show that the expression of X-MyT1 is negatively as well as the ectopic neurogenesis induced by the regulated by lateral inhibition. Overexpression of X-MyT1 ectopic expression of X-NGNR-1. Second, ectopic exis able to promote ectopic neuronal differentiation, but pression of X-MyT1 leads to a neurogenic phenotype, only in combination with bHLH transcription factors.
where more N-tubulin-expressing cells are present in Such combinations render neuronal differentiation ineach "proneural" domain. For the reasons discussed sensitive toward lateral inhibition. Furthermore, by use further below, this phenotype is not unlike the one obof a dominant-negative approach, we provide evidence tained when lateral inhibition is blocked (Chitnis and that X-MyT1 is essential to neuronal differentiation. We Kinter, 1996) . Third, X-MyT1 can cooperate with the propose that through its cooperation with bHLH genes, bHLH transcription factors to promote ectopic and pre-X-MyT1 renders cells insensitive to Notch signaling, thus mature neuronal differentiation, even in nonneural ectopromoting differentiation during the late phases of neuderm. Finally, X-MyT1 will overcome the inhibitory ronal specification.
effects of activated Notch on the proneural activity of X-NGNR-1. Thus, the results of both loss-of-function X-MyT1 Acts Downstream of X-NGNR-1 and gain-of-function experiments are consistent with Comparing the expression pattern of X-MyT1 during the idea that X-MyT1 is an essential component for proprimary neurogenesis to those of X-NGNR-1, X-Delta-1, moting neuronal differentiation during primary neuroNeuroD, and N-tubulin reveals several important features in the regulation of X-MyT1 during the period when genesis.
X-MyT1 Acts as a Transcriptional Activator
well as its ability to activate downstream targets that are required for neuronal differentiation, including NeuroD. In transient transfection assays, X-MyT1 acts as a transcription activator on reporter-gene constructs that conThese interactions between the proneural (i.e., X-NGNR-1) and the neurogenic (i.e., Delta/Notch) genes presumably tain multiple copies of the core-consensus recognition site. Deletion analysis indicates that either one of the explain why only a subset of cells emerges as neurons from a larger domain of equipotential cells. However, zinc finger clusters in combination with the central domain is sufficient for this activity or for the induction of this simple model poses a paradox. If proneural genes such as X-NGNR-1 promote lateral inhibition, how do N-tubulin gene transcription when expressed together with bHLH transcription factors in embryos. The fact cells expressing X-NGNR-1 escape the inhibitory effects of Notch signaling and differentiate? that N-tubulin expression closely follows that of X-MyT1 led us to ask whether N-tubulin is a direct or indirect
The properties of X-MyT1 described above led us to propose that X-MyT1 acts in part by allowing cells to target for X-MyT1 regulation. Indeed, in transient transfection assays, X-MyT1 can activate a reporter construct escape lateral inhibition and to differentiate during the later phases of neuronal specification. Indeed, several containing the transcription start site and about 3.5 kb of 5Ј-upstream sequence from the N-tubulin gene. This lines of evidence suggest that X-MyT1 does overcome the lateral inhibitory machinery. First, overexpression of activation is presumably mediated through an element identified by DNase I footprinting that contains an X-MyT1 leads to a neurogenic phenotype similar to that seen when lateral inhibition is blocked using a dominant-X-MyT1 binding site resembling one copy of the coreconsensus sequence (E. J. B. and T. P., unpublished negative form of X-Delta-1. Thus, when X-MyT1 is no longer limiting, the phenotype is produced as if lateral data). Thus, our results demonstrate that X-MyT1 functions as a transcription activator and that the N-tubulin inhibition were no longer active. Second, coinjections of X-MyT1 with XASH-3 or X-NGNR-1 lead to extensive gene promoter might indeed serve as a direct target for the X-MyT1 transcription factor. However, due to the ectopic neuronal differentiation, even in the presence of activated Notch, suggesting that once a cell exsomewhat promiscuous DNA-binding activity of the X-MyT1 zinc finger repeats, we do not view these in vitro presses X-MyT1 and the relevant bHLH transcription factor, this cell is no longer sensitive to lateral inhibition. data as conclusive experimental evidence, but await the demonstration that the DNA sequence element recogIn these experiments, X-MyT1 is not likely to be disabling the lateral inhibition machinery directly, since ectopic nized by X-MyT1 in vitro is also required for X-MyT1-mediated N-tubulin gene activation in vivo.
X-MyT1 expression does not affect the expression of X-Delta-1. Rather, we suggest that in the presence of In sum, our current interpretation is that X-MyT1 is a transcriptional activator, acting on target genes such as X-MyT1, neural bHLH transcription factors can activate the promoters of neuronal differentiation genes such as N-tubulin that are necessary for neuronal differentiation. However, the ability of X-MyT1 to act at these promoters N-tubulin, even when the lateral inhibitory machinery is active. Thus, whether or not a cell differentiates into a in Xenopus embryos appears to depend on cooperation with bHLH transcription factors. This cooperation may primary neuron may depend on whether or not a cell reaches a certain threshold in the levels of X-MyT1 exbe direct, as has been shown for the MAD-box transcription factor MEF-2 and the myogenic bHLH transcription pression, and this may depend on positive regulation by the bHLH transcription factors on the one hand and factor myogenin on the promoters of muscle differentiation genes (Molkentin et al., 1995) . Such a direct interacnegative regulation by the lateral inhibitory machinery on the other. Once a cell expresses sufficient levels of tion between X-MyT1 and bHLH transcription factors could reflect cooperativity on the promoters of genes X-MyT1, it, along with the relevant bHLH transcription factor, may then render terminal differentiation irreversrequired for neuronal differentiation. Alternatively, X-MyT1 may be acting indirectly by activating the expression of ible, at least in respect to Notch signaling. Our data strongly suggest that X-MyT1 interacts with other cofactors that are required by bHLH transcription factors for the regulation of neuronal differentiation bHLH transcription factors to promote neuronal differentiation. However, we do not know at what point during genes.
the cascade of bHLH gene expression this interaction becomes meaningful in terms of promoting neuronal Model for X-MyT1 Action during differentiation. The evidence thus far suggests that all Primary Neurogenesis neural bHLH factors are interchangeable in terms of their The formation of primary neurons appears to be proability to synergize with X-MyT1 to promote N-tubulin moted by bHLH transcription factors that are sequenexpression. Thus, whether X-MyT1 normally interacts tially activated in a unidirectional cascade (Ma et al., with X-NGNR-1, with NeuroD, or with other yet to be 1996). The earliest of these transcription factors to act discovered bHLH transcription factors expressed during is most likely X-NGNR-1, which is expressed as early neurogenesis remains to be determined. which in turn represses the expression of X-NGNR-1 as correspond to the conserved sequence elements KCPTPGCD and 975 (fingers 1-6) were cloned in-frame into the EcoRI and SmaI sites of pAX4bϩ (Markmeyer et al., 1990) . Recombinant proteins were HRSLSGC, respectively, which are derived from the C2HC zinc finger modules of h-MyT1. PCR products were cloned into pCRII-TA produced and immunopurified using an antibody directed against the ␤-gal domain as described previously (Nietfeld et al, 1990) . The (In Vitrogen) and sequenced. The X-MyTI PCR products were then used to screen a gt10 cDNA library prepared from stage 17 emrandom DNA oligonucleotides used in the selection experiments were AAG GGG TTG GCT GTC AAT C (N 13 or N 26 ) GGG GAG GAG bryos (Kintner and Melton, 1987) . A 3.6 kb cDNA clone was isolated and sequenced on both strands. The same degenerate primers were AAG GGG AG. For PCR amplification, the oligonucleotides 5Ј AAG GGG TTG GCT GTC AAT C and 5Ј CTC CCC TTC TCC TCC CC also used on random-primed cDNA templates prepared from E18 rat embryonic brain and C. elegans embryos. PCR products were served as forward and reverse primers, respectively. The doublestranded DNA substrates were synthesised by annealing with the cloned and sequenced. The rat MyT2/3 cDNA clones were obtained by screening a ZAP cDNA library prepared from neonatal rat cortex reverse primer and extending with Taq polymerase (Promega) as cDNA library (Sahin and Hockfield, 1993 ) using the rat fragments described (Delwel et al., 1993) but with the addition of a [ 32 P]dCTP. isolated by RT-PCR as probes. The C. elegans MyT1 cDNA clone Random catch-linked HaeIII digested genomic DNA from Xenopus was PCR amplified from a ZAP cDNA library (Barstead and Walaevis was prepared as described (Kinzler and Vogelstein, 1990 ) but terson, 1989) using specific primers derived from the C. elegans using T4 kinase-labeled catch linkers (5ЈGAG TAG AAT TCT AAT RT-PCR fragments (5Ј CGT AGA CCA GAC AAG ACT G 3Ј and 5Ј ATC TC and 5ЈGAG ATA TTA GAA TTC TAC TC). Labeled genomic CTA TTT CCA TTG ACA TGT CCC 3Ј) and T7 and T3 primers flanking DNA and random double-stranded oligonucleotides were incubated the ZAP cloning site. All sequencing was performed with Sequewith ␤-galactosidase fusion proteins in binding buffer and pronase (U.S. Biochemicals) or on an Applied Biosystems sequencing cessed as described (Nietfeld et al., 1990; Theunissen et al., 1992) . system, using Taq dye terminator cycle sequencing.
Successive rounds of selection were performed in increasing salt concentration (up to 200 mM for the oligonucleotides selection, up Wholemount In Situ Hybridization and Histology to 600 mM for the genomic DNA selection) in order to select for Wholemount in situ hybridization was performed as described high-affinity binding sites. After each round of selection, protein using digoxigenin-labeled antisense RNA A-Sepharose bound DNA-protein complexes were resuspended in probes. The X-MyT1 RNA probe was prepared from a X-MyT1 subwater, phenol extracted, and ethanol precipitated. One fifth of the fragment corresponding to amino acids 459 to 894. Preparation of selected DNA was used for the next round of PCR amplication in probes for X-Delta-1 , NeuroD , the presence of a [ 32 P]dCTP. After 6 to 8 rounds of selection, the DNA X-NGNR-1 , and N-tubulin (Oschwald et al., 1991, was cloned into the pCRII vector. For each selection experiment, we Chitnis et al., 1995) was as described previously. Double-labeling determined the sequences of about 50 independent clones. DNAseI wholemount in situ hybridization has been performed using digoxifootprinting analysis was performed exactly as described previously genin UTP and fluorescein UTP probes hybridized simultaneously (Theunissen et al., 1992) . but visualized sequentially with the corresponding specific alkaline phosphatase conjugates. The fluoresceine-labeled probe was de-DNA Transfection and CAT Assays tected first using Fast Red (Boerhinger). The alkaline phosphatase CMV promoter expression vector constructs encoding X-MyT1 fullactivity was then destroyed by heating in MAb ϩ 0.1 M EDTA at 65ЊC length and truncated versions were the same as those used in the for 30 min. The second digoxigenin-labeled probe was visualized by embryo microinjection experiments. The reporter construct contains use of NBT/BCIP. For sectioning, stained and postfixed embryos a selected 26 bp DNA fragment (5Ј AGC AAA AAG TTT ATT CAA were gelatin-embedded and vibratome-sectioned at 30 m thick-AAG TTT C; MyTI binding sites are underlined) cloned into the HindIII ness. Images from embryos and mounted sections visualized using and XbaI sites upstream of the minimal TK promoter in the pBLCAT2 Normarski optics were acquired with a CCD camera (Sony).
plasmid (Luckow and Schutz, 1987) . Hela cells maintained in Dulbecco's modified Eagle's medium (DMEM) and 10% fetal calf serum Microinjection Procedures were transfected by electroporation. Transfection mixtures always The full-length coding region of X-MyT1 was cloned in-frame into contained 10 g each of reporter and expression plasmids. Fortythe EcoRI-XbaI site of the pCS2MT (Turner and Weintraub, 1994) eight hours after transfection, cell extracts were prepared and equivvector by PCR amplification from the original cDNA phage with the alent amounts of protein were used in each series of CAT assays. 5Ј primer (5Ј GAC CGG AAT TCC AAT GTA GAC AAT GTT AAC; All transfections were repeated at least three times. Levels of CAT EcoRI site underlined) and the 3Ј primer (5Ј GAC GCT CTA GAC activity were quantified from TLC plates on a PhosphorImager (Mo-TGG TGG CTT CCA GAC C). The resulting plasmid was termed lecular Dynamics). pCS2MTX-MyT1. All truncated versions of X-MyT1 were generated by PCR from the pCS2MTX-MyT1 and cloned in-frame into the EcoRI
